CLNN $0.45 -has Blockbuster drug (ALS treatment) with potential accelerated FDA approval by next year . stock trading near cash and there was some big insider buying at higher price in last few months see link below . they will meet with FDA in the coming days to talk about a accelerated NDA submission if FDA gives green light then the stock likely will rally .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.